Skip to main content
SpringerLink
Log in

Premenstrual Syndrome

Identification and Management

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Premenstrual syndrome is a legitimate illness consisting of the cyclic recurrence of symptoms (physical, mental and behavioural) in the late luteal phase of the menstrual cycle of sufficient severity to require treatment. The syndrome has a yet unknown aetiology, an uncertain and variable course, and an unidentified family history. Methods are available for diagnosis including obtaining a reliable history, thorough physical and mental examinations, laboratory tests to exclude other possible causes of symptoms, and daily prospective symptom ratings to confirm symptom patterns. Because there is no known aetiology, treatment consists of symptom management of the specific symptoms experienced, based on prospective symptom ratings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gold JH, Severino SK, editors. Premenstrual dysphorias: myths and realities. Washington, DC: American Psychiatric Press, Inc., 1994

    Google Scholar 

  2. Reid RL, Yen SSC. The premenstrual syndrome. Clin Obstet Gynecol 1983; 26: 710–8

    Article  PubMed  CAS  Google Scholar 

  3. Harrison M. Self-help for premenstrual syndrome. New York: Random House, 1982

    Google Scholar 

  4. Mitchell ES, Woods NF, Lentz MJ. Recognizing PMS when you see it: criteria for PMS sample selection. In: Taylor DL, Woods NF, editors. Menstruation, health and illness. Washington DC: Hemisphere, 1991: 89–102

    Google Scholar 

  5. Mitchell ES, Woods NF, Lentz MJ. Differentiation of women with three premenstrual symptoms patterns. Nurs Res 1994 Jan-Feb; 43 (1): 25–30

    Article  PubMed  CAS  Google Scholar 

  6. Committee Statement 66 of the American College of Obstetricians and Gynecologists. American College of Obstetricians and Gynecologists, Washington, DC, January 1987

  7. Stout AL, Steege JF. Psychological assessment of women seeking treatment for premenstrual assessment. J Psychosom Res 1985; 29: 621–9

    Article  PubMed  CAS  Google Scholar 

  8. Rivera-Tovar AD, Frank E. Late luteal phase dysphoric disorder in young women. Am J Psychiatry 1990; 147: 1634–36

    PubMed  CAS  Google Scholar 

  9. Backstrom T, Boyle H, Baird DT. Persistence of symptoms of premenstrual tension in hysterectomized women. Br J Obstet Gynaecol 1981; 88: 530–6

    Article  PubMed  CAS  Google Scholar 

  10. Adenaike OC, Abidoye RO. A study of the incidence of the premenstrual syndrome in a group of Nigerian women. Public Health 1987; 101: 49–58

    Article  PubMed  CAS  Google Scholar 

  11. Hasin M, Dennerstein L, Gotts G. Menstrual cycle related complaints: cross-cultural study. J Psychosom Obstet Gynecol 1988; 9: 35–42

    Article  Google Scholar 

  12. Janinger O, Riffenburgh R, Karsh R. Cross cultural study of premenstrual symptoms. Psychosomatics 1972; 13: 226–35

    Google Scholar 

  13. Wilson CA, Turner CW, Keye WR. Firstborn adolescent daughters and mothers with and without premenstrual syndrome: a comparison. J Adolesc Health 1991; 12: 130–7

    Article  PubMed  CAS  Google Scholar 

  14. Kendler KS, Silberg JL, Neale MC, et al. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: a population-based twin study. Psychol Med 1992; 22: 85–100

    Article  PubMed  CAS  Google Scholar 

  15. Condon JT. The premenstrual syndrome: a twin study. Br J Psychiatry 1993; 162: 481–6

    Article  PubMed  CAS  Google Scholar 

  16. Kantero RL, Widholm O. A statistical analysis of the menstrual patterns of 8,000 Finnish girls and their mothers: IV. Correlations of menstrual traits between adolescent girls and their mothers. Acta Obstet Gynecol Scand 1971; 14 Suppl.: 30–6

    Article  Google Scholar 

  17. Dalton K, Dalton M, Guthrie K. Incidence of the premenstrual syndrome in twins. BMJ 1987; 295: 1027–8

    Article  PubMed  CAS  Google Scholar 

  18. Van den Akker OB, Steen GS, Neale MC, et al. Genetic and environmental variation in menstrual cycle: histories of two British twin samples. Acta Genet Med Gemellol 1987; 36: 541–8

    PubMed  Google Scholar 

  19. Severino SK, Moline ML. Premenstrual syndrome: a clinician’s guide. New York: Guilford Press, 1989

    Google Scholar 

  20. Severino SK. Late luteal phase dysphoric disorder: a scientific puzzle. Med Hypotheses 1993; 41 (3): 229–34

    Article  PubMed  CAS  Google Scholar 

  21. Morse CA, Dennerstein L, Varnavides K, et al. Menstrual cycle symptoms: comparison of a non-clinical sample with a patient group. J Affect Disord 1988; 14: 41–50

    Article  PubMed  CAS  Google Scholar 

  22. Rapkin AJ, Chang LC, Reading AE. Comparison of retrospective and prospective assessment of premenstrual symptoms. Psychol Rep 1988; 62: 55–60

    Article  PubMed  CAS  Google Scholar 

  23. Schnurr PP, Hurt SW, Stout AL. Consequences of methodological decisions in the diagnosis of late luteal phase dysphoric disorder. In: Gold JH, Severino SK, editors. Premenstrual dysphorias: myths and realities. Washington, DC: American Psychiatric Press, Inc., 1994: 19–46

    Google Scholar 

  24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press, Inc., 1994: 715–8

    Google Scholar 

  25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd rev. ed. Washington, DC: American Psychiatric Press, Inc., 1987: 367–9

    Google Scholar 

  26. Pearlstein T, Rivera-Tovar A, Frank E, et al. Nonmedical management of late luteal phase dysphoric disorder: a preliminary report. J Psychother Pract Res 1992; 1: 49–55

    PubMed  CAS  Google Scholar 

  27. Reid RL, Maddocks SE. A positive approach to PMS. Contemp Obstet Gynecol 1987 April; 41-54

  28. Rossignol AM, Zhang JY, Chen YZ, et al. Tea and premenstrual syndrome in the People’s Republic of China. Am J Public Health 1989; 79: 67–9

    Article  PubMed  CAS  Google Scholar 

  29. MacGregor GA, Markandu ND, Roulston JE, et al. Is ‘idiopathic’ oedema idiopathic?. Lancet 1979; 1: 397–400

    Article  PubMed  CAS  Google Scholar 

  30. Prior JC, Vigna Y. Conditioning exercise and premenstrual symptoms. J Reprod Med 1987; 32: 423–8

    PubMed  CAS  Google Scholar 

  31. Steege JF, Blumenthal JA. The effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study. J Psychosom Res 1993; 37: 127–33

    Article  PubMed  CAS  Google Scholar 

  32. Kleijnen J, Riet GT, Knipschild P. Vitamin B6 in the treatment of the premenstrual syndrome — a review. Br J Obstet Gynaecol 1990; 97: 847–52

    Article  PubMed  CAS  Google Scholar 

  33. Doll H, Brown S, Thurston A, Vessey M. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial. J Royal Coll Gen Pract 1989; 9: 364–8

    Google Scholar 

  34. Andersch B, Hahn L. Premenstrual complaints: II. Influence of oral contraceptives. Acta Obstet Gynecol Scand 1981; 60: 579–83

    Article  CAS  Google Scholar 

  35. Kutner SJ, Brown WL. Types of oral contraceptives, depression and premenstrual symptoms. J Nerv Ment Dis 1972; 155: 153–62

    Article  PubMed  CAS  Google Scholar 

  36. Herzberg B, Coppen A. Changes in psychological symptoms in women taking oral contraceptives. Br J Psychiatry 1970; 116: 161–4

    Article  PubMed  CAS  Google Scholar 

  37. Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res. 1992; 36: 257–66

    Article  PubMed  CAS  Google Scholar 

  38. Backstrom T, Hansson-Malmstrom Y, Lindhe BA, et al. Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations. Contraception 1992; 46: 253–68

    Article  PubMed  CAS  Google Scholar 

  39. Bancroft J, Rennie D. The impact of oral contraceptives on the experience of perimenstrual mood clumsiness, food craving and other symptoms. J Psychosom Res 1993; 37: 195–202

    Article  PubMed  CAS  Google Scholar 

  40. Bancroft J, Boyle H, Warner P, et al. The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes. Clin Endocrinol 1987; 27: 171–82

    Article  CAS  Google Scholar 

  41. Hammarback S, Backstrom T. Induced anovulation as treatment of premenstrual tension syndrome. Acta Obstet Gynecol Scand 1988; 67: 159–66

    Article  PubMed  CAS  Google Scholar 

  42. Muse KN. Clinical experience with the use of GnRH agonists in the treatment of premenstrual syndrome. Obstet Gynecol Survey 1989; 44: 317–8

    Article  CAS  Google Scholar 

  43. Muse KN, Cetel NS, Futterman LA, et al. The premenstrual syndrome: effects of medical ovariectomy. N Engl J Med 1984; 311: 1345–9

    Article  PubMed  CAS  Google Scholar 

  44. Reid RL, Yen SSC. LHRH agonists and antagonists: therapeutic possibilities for premenstrual syndrome. In: Vickery BH, Nestor JJ, Hafez ESE, editors. LHRH and its analogs. Lancaster, England: MTP Press, 1987: 279–93

    Chapter  Google Scholar 

  45. West CP, Lumsden MA, Baird DT. Modification of symptoms of the premenstrual syndrome during ovarian suppression with goserelin (Zoladex) depot: potential for research and clinical investigation. J Psychosom Obstet Gynaecol 1989; 10: 79–88

    Article  Google Scholar 

  46. Mortola JF, Girton L, Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 1991; 72: 252A-F

    Article  Google Scholar 

  47. Casper RF, Hearn MT. The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome. Am J Obstet Gynecol 1990; 162: 105–9

    PubMed  CAS  Google Scholar 

  48. Casson P, Hahn PM, Van Vugt DA, et al. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol 1990; 162: 99–105

    PubMed  CAS  Google Scholar 

  49. Riggs L, Melton LJ. Involutional osteoporosis. N Engl J Med 1986; 314: 1676–86

    Article  PubMed  CAS  Google Scholar 

  50. Studd J. Prophylactic oophorectomy. Br J Obstet Gynaecol 1989; 96: 506–8

    Article  PubMed  CAS  Google Scholar 

  51. Watts JF, Butt WR, Edwards RL. A clinical trial using danazol for the treatment of premenstrual tension. Br J Obstet Gynaecol 1987; 94: 30–4

    Article  PubMed  CAS  Google Scholar 

  52. Sarno Jr AP, Miller Jr EJ, Lundblad EG. Premenstrual syndrome: beneficial effects of periodic, low-dose danazol. Obstet Gynecol 1987; 70: 30–6

    Google Scholar 

  53. Derzko CM. Role of danazol in relieving the premenstrual syndrome. J Reprod Med 1990; 35 Suppl: 99–102

    Google Scholar 

  54. Deeny M, Hawthorne R, Hart DM. Low dose danazol in the treatment of the premenstrual syndrome. Postgrad Med J 1991; 67: 450–4

    Article  PubMed  CAS  Google Scholar 

  55. Halbreich U, Rojansky N, Palter S. Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. Fertil Steril 1991; 56: 1066–9

    PubMed  CAS  Google Scholar 

  56. Magos AL, Brincat M, Studd JWW. Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: placebo-controlled study. BMJ 1986; 292: 1629–33

    Article  PubMed  CAS  Google Scholar 

  57. Watson NR, Studd JWW, Savvas M, et al. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 1989; 2: 730–2

    Article  PubMed  CAS  Google Scholar 

  58. Moline ML. Pharmacologic strategies for managing premenstrual syndrome. Clin Pharm 1993; 12: 181–96

    PubMed  CAS  Google Scholar 

  59. Smith S, Rinehart JS, Ruddock VE, et al. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled randomized crossover clinical trial. Obstet Gynecol 1987; 70: 37–42

    PubMed  CAS  Google Scholar 

  60. Harrison WM, Endicott J, Nee J. Treatment of premenstrual dysphoria with alprazolam: a controlled study. Arch Gen Psychiatry 1990; 47: 270–5

    Article  PubMed  CAS  Google Scholar 

  61. Schmidt PF, Grover GN, Rubinow DR. Alprazolam in the treatment of premenstrual syndrome. Arch Gen Psychiatry 1993; 50: 467–73

    Article  PubMed  CAS  Google Scholar 

  62. Ayd Jr FJ. Benzodiazepine seizures; an update. Int Drug Ther News 1989; 24: 5–7

    Google Scholar 

  63. Schmidt PJ, Grover GN, Rubinow DR. Alprazolam in the treatment of premenstrual syndrome: a double-blind, placebocontrolled trial. Arch Gen Psychiatry 1993; 50: 467–73

    Article  PubMed  CAS  Google Scholar 

  64. Smith S, Rinehart JS, Ruddock VE et al. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo- controlled randomized crossover clinical trial. Obstet Gynecol 1987; 70: 37–42

    PubMed  CAS  Google Scholar 

  65. David D, Freeman A, Harrington TM, et al. Buspirone for anxious women in a primary care environment; a multicenter open evaluation. Adv Ther 1987; 4: 251–64

    Google Scholar 

  66. Rickels K, Freeman E, Sondheimer S. Buspirone in treatment of premenstrual syndrome [letter]. Lancet 1989; 1: 777

    Article  PubMed  CAS  Google Scholar 

  67. Harrison WM, Endicott J, Nee J. Treatment of premenstrual depression with nortriptyline: a pilot study. J Clin Psychiatry 1989; 50: 136–9

    PubMed  CAS  Google Scholar 

  68. Severino SK. A focus on 5-hydroxytryptamine (serotonin) and psychopathology. In: Gold JH, Severino SK, editors. Premenstrual dysphorias: myths and realities. Washington, DC: American Psychiatric Press, Inc., 1994: 67–98

    Google Scholar 

  69. Pearlstein TB, Stone AB. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1994; 55(8): 332–5

    PubMed  CAS  Google Scholar 

  70. Daamen MJ, Brown WA. Single-dose fluoxetine in management of premenstrual syndrome. J Clin Psychiatry 1992; 53: 210–1

    PubMed  CAS  Google Scholar 

  71. Werch R, Kane R. Treatment of premenstrual tension with metolazone: a double-blind evaluation of a new diuretic. Curr Ther Res 1976; 19: 565–72

    PubMed  CAS  Google Scholar 

  72. Andersch B, Hahn L, Andersson M, et al. Body water and weight in patients with premenstrual tension. Br J Obstet Gynaecol 1978; 85: 546–50

    PubMed  CAS  Google Scholar 

  73. Rivera-Tovar A, Rhodes R, Pearlstein TB, et al. Treatment efficacy. In: Gold JH, Severino SK, editors. Premenstrual dysphorias: myths and realities. Washington, DC: American Psychiatric Press, Inc., 1994: 99–148

    Google Scholar 

  74. Andersen AN, Larsen JF, Steenstrup OR, et al. Effect of bromocriptine on the premenstrual syndrome: a double-blind clinical trial. Br J Obstet Gynaecol 1977; 84: 370–4

    Article  PubMed  CAS  Google Scholar 

  75. Graham JJ, Harding PE, Wise PH, et al. Prolactin suppression in the treatment of premenstrual syndrome. Med J Aust 1978; 2: 18–20

    PubMed  Google Scholar 

  76. Kullander S, Svanberg L. Bromocriptine treatment of the premenstrual syndrome. Acta Obstet Gynecol Scand 1979; 58: 375–8

    Article  PubMed  CAS  Google Scholar 

  77. Eisner CW, Buster JE, Schindler RA, et al. Bromocriptine in the treatment of premenstrual tension syndrome. Obstet Gynecol 1980; 56: 723–6

    Google Scholar 

  78. Ylostalo P. Cyclical or continuous treatment of the premenstrual syndrome (PMS) with bromocriptine. Euro J Obstet Gynecol Reprod Biol 1984; 17: 337–43

    Article  CAS  Google Scholar 

  79. Messinis IE, Lolis D. Treatment of premenstrual mastalgia with tamoxifen. Acta Obstet Gynecol Scand 1988; 67: 307–9

    PubMed  CAS  Google Scholar 

  80. Seachrist L. Animal tests take back seat to clinical data. Science 1994; 264: 1525

    Article  PubMed  CAS  Google Scholar 

  81. Robinson K, Huntington KM, Wallace MG. Treatment of premenstrual syndrome. Br J Obstet Gynecol 1977; 84: 784–8

    Article  CAS  Google Scholar 

  82. Barwin BN. The management of premenstrual tension syndrome. Fertil Steril 1980; 34: 187–8

    Google Scholar 

  83. Wurtman J, Brzezinski A, Wurtman RJ et al. Effect of nutrient intake on premenstrual depression. Am J Obstet Gynecol 1989; 161: 1228–34

    PubMed  CAS  Google Scholar 

  84. Rossignol AM, Bonnlander H. Prevalence and severity of the premenstrual syndrome: effects of foods and beverages that are sweet or high in sugar content. J Reprod Med 1991; 36: 131–6

    PubMed  CAS  Google Scholar 

  85. O’Rourke D, Wurtman JJ, Wurtman RJ, et al. Treatment of seasonal depression with d-fenfluramine. J Clin Psychiatry 1989; 50: 343–7

    PubMed  Google Scholar 

  86. Brzezinski AA, Wurtman JJ, Wurtman RJ, et al. d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of woman with premenstrual depression. Obstet Gynecol 1990; 76: 296–301

    PubMed  CAS  Google Scholar 

  87. Thys-Jacobs S, Ceccarelli S, Bierman A et al. Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med 1989; 4: 183–9

    Article  PubMed  CAS  Google Scholar 

  88. Alvir JMJ, Thys-Jacobs S. Premenstrual and menstrual symptom clusters and response to calcium treatment. Psychopharm Bull 1991; 27: 145–8

    CAS  Google Scholar 

  89. Severino SK, Yonkers K. A review of psychotic symptoms associated with the premenstruum. Psychosomatics 1993; 34: 299–306

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, New York Hospital-Cornell Medical Center, Westchester Division, 21 Bloomingdale Road, White Plains, New York, 10605, USA

    Sally K. Severino & Margaret L. Moline

Authors
  1. Sally K. Severino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margaret L. Moline
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Severino, S.K., Moline, M.L. Premenstrual Syndrome. Drugs 49, 71–82 (1995). https://doi.org/10.2165/00003495-199549010-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199549010-00006

Keywords

Search

Navigation